comparemela.com

Latest Breaking News On - Jianmin fang - Page 3 : comparemela.com

UPenn, which hosts Biden s think tank, sees Chinese, CCP-linked donations soar

The university housing President Biden's think tank recently saw its donations from China triple from its previous reporting period, records show.

United statesHong kongDepartment of educationDistrict of columbiaWharton schoolNew yorkNei mongolWang xingWhite houseUniversity of pennsylvaniaTung chee hwaKathy xuMeituan dianpingCaitlin sutherlandWeidong wangMa jianrong

UPenn, which hosts Biden s think tank, sees Chinese donations soar, including from CCP-linked sources

The university housing President Biden's think tank recently saw its donations from China triple from its previous reporting period, records show.

Hong kongUnited statesDepartment of educationDistrict of columbiaNei mongolUniversity of pennsylvaniaNew yorkWhite houseJianmin fangStephen maccarthyWeidong wangAntony blinkenMa jianrongCentral committeeZhejiang provincial people congressShenzhou international

RC88 Gets Fast Track Designation for Gynecologic Cancer Treatment

The FDA granted a Fast Track Designation to RC88, a novel antibody-drug conjugate, to treat patients with platinum-resistant gynecologic cancers.

Jianmin fangDrug administrationRemegen coFast track designationAntibody drug conjugatesPatients withInvestigational new drugGynecologic cancer

RemeGen s RC88 Obtained FDA Fast Track Designation, Heralds New Hope for Ovarian Cancer Patients

RemeGen s RC88 Obtained FDA Fast Track Designation, Heralds New Hope for Ovarian Cancer Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJianmin fangRemegen coDrug administrationPrnewswire remegen coEuropean unionRemegen co ltdFast track designation

FDA Grants Fast Track Designation to RC88 in Platinum-Resistant Recurrent Ovarian Cancer

The FDA has granted a fast track designation to RC88, a mesothelin-targeting antibody-drug conjugate for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Jianmin fangOvarian cancerFast track designationAntibody drug conjugate

vimarsana © 2020. All Rights Reserved.